Muhlenkreiskliniken Minden, Ruhr University Bochum

Bochum, North Rhine-Westphalia 44791

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma — Running, not enrolling